↓ Skip to main content

Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease lead to depression?

Overview of attention for article published in Expert Opinion on Drug Metabolism & Toxicology, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#50 of 856)
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
1 news outlet
twitter
1 tweeter

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease lead to depression?
Published in
Expert Opinion on Drug Metabolism & Toxicology, June 2021
DOI 10.1080/17425255.2021.1931681
Pubmed ID
Authors

Miloš Mitić, Tamara Lazarević-Pašti

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 11%
Student > Postgraduate 2 11%
Researcher 2 11%
Student > Ph. D. Student 1 6%
Lecturer > Senior Lecturer 1 6%
Other 2 11%
Unknown 8 44%
Readers by discipline Count As %
Unspecified 2 11%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Biochemistry, Genetics and Molecular Biology 2 11%
Environmental Science 1 6%
Psychology 1 6%
Other 2 11%
Unknown 8 44%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 May 2021.
All research outputs
#2,679,135
of 21,239,792 outputs
Outputs from Expert Opinion on Drug Metabolism & Toxicology
#50
of 856 outputs
Outputs of similar age
#63,538
of 345,679 outputs
Outputs of similar age from Expert Opinion on Drug Metabolism & Toxicology
#1
of 10 outputs
Altmetric has tracked 21,239,792 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 856 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,679 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them